Skip to main content
Veterinary Medicines

Soliphen 60 mg tablets for dogs

Authorised
  • Phenobarbital

Product identification

Medicine name:
SOLIPHEN 60 mg comprimidos para cães
Soliphen 60 mg tablets for dogs
Active substance:
  • Phenobarbital
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenobarbital
    60.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN03AA02
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID3) 300 Tablet: unspecified outer container with 25 Blister (PolyVinyl Chloride) each with 12 Tablet
  • (ID2) 180 Tablet: unspecified outer container with 15 Blister (PolyVinyl Chloride) each with 12 Tablet
  • (ID1) 60 Tablet: unspecified outer container with 5 Blister (PolyVinyl Chloride) each with 12 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 916/01/15DFVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0305/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 17/04/2024
Download
Portuguese (PDF)
Published on: 5/12/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."